Okomera (private company)
See something wrong or missing? Let us know
Offices:Paris
Business model:B2B
Okomera is a biotech startup from France developing improved, precision-based cancer therapies, as it pioneers automation and miniaturization of personalized tumor biopsy studies.
Investors:
we tracked 5 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 11.03M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Okomera
Name | Criteria | |
---|---|---|
![]() |
Atai Life Sciences
73%
|
|
![]() |
Combinostics
73%
|
|
![]() |
Corti Labs
73%
|
|
![]() |
Globus AI
73%
|
|
![]() |
iLoF
73%
|
|
![]() |
Monocl
73%
|
|
![]() |
Psyomics
73%
|
|
![]() |
Sano Genetics
73%
|
|
![]() |
Skin Analytics
73%
|
|
![]() |
Teton.ai
73%
|
|